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Authors' Reply
We thank Ms. Dillon for her interest and comments on our study of commercially available broth microdilution panels for detection of penicillin-resistant pneumococci (2) . It is her contention that deviations from methods described in the Pasco package insert (3) accounted for the fact that 86% of the test strains failed to grow in Pasco panels when the Difco MIC blood supplement (10% lysed horse blood [LHB]) in distilled water, product 6661-42-7) was used. The method we described for these panels was an attempt to resolve an apparent discrepancy in the instructions contained in that package insert.
The package insert indicated that the inoculum for fastidious, slowly growing organisms should be prepared by using the turbidity method and that the subsequent dilution should be prepared in an appropriate supplemental diluent. NCCLS document M7-A3 (1) was given as a reference. The package insert also described a one-step inoculation procedure which simultaneously provided for inoculation of the test organism and supplementation of the broth. If the instructions in the package insert were followed, the final LHB concentration would have been 0.5% rather than the 2 to 5% recommended by NCCLS. In order to achieve a final concentration of LHB within the recommended range, we chose to add 100 l of the MIC blood supplement to each of the wells. This addition reduced the concentrations of penicillin and Mueller-Hinton broth by one-half. We agree with Ms. Dillon that the resulting nutritionally deficient medium may have accounted for the poor growth of the test strains. Support for this hypothesis was provided in our study. Supplementation of the panel with 100 l of 5% LHB prepared in Mueller-Hinton broth rather than water allowed for good growth of all the test strains.
The current package insert (4) describes inoculum preparation using 12.5 ml of SP blood supplement (product 6875-42-0) and indicates that the final concentration of the LHB will be approximately 2.5%. Apparently the LHB supplement has been modified to more closely approximate the NCCLS recommendations. We are pleased to learn that the recent modifications made by the manufacturer have significantly improved the ability of this test system to support the growth of pneumococci and to accurately detect penicillin-resistant strains. 
